Literature DB >> 2051255

Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.

J H Beijnen1, A U Beijnen-Bandhoe, A C Dubbelman, R van Gijn, W J Underberg.   

Abstract

The chemical and physical stabilities of the cytotoxic drugs etoposide and teniposide have been investigated in three different, commonly used, infusion fluids. Chemical stability has been measured by a stability indicating reversed-phase high-performance liquid chromatographic assay with ultraviolet detection. Physical stability was checked by visual inspection and the presence of microparticles was inspected by viewing the admixtures against a white and dark background of a light box equipped with an incandescent lamp and a polarizing filter. Samples were also tested for changes in pH. It is concluded that etoposide and teniposide in 5% dextrose and 0.9% sodium chloride infusion fluids (concentration: 0.4 mg/mL) are chemically stable for at least four days at room temperature. Stability of the drugs is not influenced by the presence of normal room fluorescent light nor by the type of container material used (glass bottles or polyvinyl chloride minibags). Occasional precipitation occurred in etoposide infusion fluids with a concentration higher than 0.4 mg/mL. Teniposide infusion solutions were physically stable at the tested concentrations up to 0.7 mg/mL.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051255

Source DB:  PubMed          Journal:  J Parenter Sci Technol        ISSN: 0279-7976


  9 in total

1.  Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.

Authors:  J Thiesen; I Krämer
Journal:  Pharm World Sci       Date:  1999-06

Review 2.  Etoposide phosphate, the water soluble prodrug of etoposide.

Authors:  A H Witterland; C H Koks; J H Beijnen
Journal:  Pharm World Sci       Date:  1996-10

3.  Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244).

Authors:  J D Jonkman-de Vries; M J de Graaff-Teulen; R E Henrar; J J Kettenes-van den Bosch; A Bult; J H Beijnen
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

4.  Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.

Authors:  Nilesh R Rarokar; Suprit D Saoji; Nishikant A Raut; Jayashree B Taksande; Pramod B Khedekar; Vivek S Dave
Journal:  AAPS PharmSciTech       Date:  2015-07-25       Impact factor: 3.246

5.  High concentrated etoposide solutions, additional physical stability data in dextrose 5.

Authors:  Marine Ravey; Caroline Polo; Elise D'Huart; Jean Vigneron; Béatrice Demoré
Journal:  Eur J Hosp Pharm       Date:  2020-10-20

6.  Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags.

Authors:  Elise D'Huart; Jean Vigneron; Pauline Lider; Béatrice Demoré
Journal:  Eur J Hosp Pharm       Date:  2018-07-07

7.  Stability of the i.v. and oral formulations of etoposide in solution.

Authors:  S P Joel; P I Clark; M L Slevin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies.

Authors:  Shufang Nie; W L Wendy Hsiao; Weisan Pan; Zhijun Yang
Journal:  Int J Nanomedicine       Date:  2011-01-19

9.  Stability of etoposide solutions in disposable infusion devices for day hospital cancer practices.

Authors:  Alison Klasen; Romain Kessari; Lionel Mercier; Cyril Valade; Jacques Grill; Romain Desmaris; Angelo Paci
Journal:  Drugs R D       Date:  2014-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.